Skip to main content

The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis

Abstract

This study was aimed to investigate the significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis (sHLH) patients. A total of 18 patients received 18F-FDG PET/CT scan at initial diagnosis. All patients (18/18) had at least 3 organs involved, with increased FDG metabolism in different degrees. Fifteen cases (15/18) had definite underlying diseases, including infections (IAHLH), rheumatosis (RAHLH), or malignancy (MAHLH). The SUVmax of patients in MAHLH group was significantly higher than patients in IAHLH group or RAHLH group (P = 0.015, P = 0.045). Furthermore, the SUVmax of patients in IAHLH group was significantly higher than patients of RAHLH group (P = 0.043). Therefore, we concluded that 18F-FDG PET/CT may especially play important role in differential diagnosis of sHLH.

To the Editor

Secondary hemophagocytic lymphohistiocytosis (sHLH) is a hyper-inflammatory clinical syndrome mainly caused by severe infections, autoimmune inflammatory disorders and malignancies, especially lymphoma [13]. Up to date, very few data from the literature are available regarding the role of 18F-FDG PET/CT in sHLH. In this study, 18 of 50 patients with sHLH who were admitted into our hospital between May 2007 and December 2010 underwent the examination (Table 1). The male-to-female ratio was 1:1, and the median age was 35 years (15-73). The diagnosis of HLH was made according to HLH-2004 diagnostic guidelines [4, 5], and the underlying diseases were confirmed by a series of pathogenesis examinations including pathology, immunology, bacterial culture and virus detection et al. The maximum standardized uptake values (SUVmax) used to measure the level of FDG uptake were determined in all lesions [6]. All of the 18 patients had at least 3 organs involved, with increased FDG uptake at different level, including 18 cases showing splenomegaly, 16 cases serous effusions, 16 cases lymphadenopathy, 13 cases bone lesions, 12 cases pneumonia, 8 cases hepatomegaly, 5 cases brain parenchymal or cerebroventricular lesions, 5 cases cholecystitis, 4 cases myocardium lesions, and 2 cases kidney calculi. There were also other organs involved, such as larynx, muscles and adnexauteri. Fifteen patients (15/18) had definite underlying diseases, and were divided into three groups.,including Infection Associated HLH (IAHLH, including EBV-HLH, n = 8), Rheumatosis Associated HLH (RAHLH, n = 2), and Malignancy Associated HLH (MAHLH, n = 5). The SUVmax of patients in MAHLH group was significantly higher than those of patients with IAHLH (Mean 12.0 vs. 6.8, P = 0.015), and RAHLH (Mean 12.0 vs. 2.7, P = 0.045). Furthermore, the SUVmax of patients with IAHLH was significantly higher than that of patients with RAHLH (Mean 6.8 vs. 2.7, P = 0.043). However, no significant difference in survival time was found between the three different sHLH subtype according to Kaplan-Meier analysis (P >0.05). In conclusion, 18F-FDG PET/CT may play important role in differential diagnosis of sHLH, with high SUV pointing toward underlying malignancy.

Table 1 Characteristics of 18 sHLH patients

References

  1. 1.

    Janka G, Imashuku S, Elinder G: Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998, 12: 435-444. 10.1016/S0889-8588(05)70521-9.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Fisman DN: Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000, 6: 601-608. 10.3201/eid0606.000608.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  3. 3.

    Dhote R, Simon J, Papo T: Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003, 49: 633-639. 10.1002/art.11368.

    Article  PubMed  Google Scholar 

  4. 4.

    Henter JI, Horne A, Aricó M: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48: 124-131. 10.1002/pbc.21039.

    Article  PubMed  Google Scholar 

  5. 5.

    Filipovich AH: Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009, 127-131.

    Google Scholar 

  6. 6.

    Huang SC: Anatomy of SUV. Nucl Med Biol. 2000, 27: 643-646. 10.1016/S0969-8051(00)00155-4.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Natural Science Foundation of China (81070456, 81170490), ‘Liu Da Ren Cai Gao Feng’ of Jiangsu Province (2010-WS-019), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Hong-Xia Qiu or Su-Jiang Zhang.

Additional information

Li-Juan Zhang, Ji Xu contributed equally to this work.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Zhang, LJ., Xu, J., Liu, P. et al. The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis. J Hematol Oncol 5, 40 (2012). https://doi.org/10.1186/1756-8722-5-40

Download citation

Keywords

  • Lymphoma
  • Vincristine
  • Cholecystitis
  • Connective Tissue Disease
  • Hemophagocytic Lymphohistiocytosis